Literature DB >> 16445956

Novel pathway of human immunodeficiency virus type 1 uptake and release in astrocytes.

Jennifer N Clarke1, Julie-Anne Lake, Christopher J Burrell, Steven L Wesselingh, Paul R Gorry, Peng Li.   

Abstract

Astrocytes persistently infected with HIV-1 can transmit virus to CD4+ cells, suggesting that astrocytes may be a source of viral persistence and dissemination in the brain. In the present study, we investigated the fate of HIV-1 upon infection of astrocytes. HIV-1 was observed in vesicle-like structures. Unspliced genomic RNA and extrachromosomal HIV-1 DNA were detected in astrocytes, with levels declining over time. The extrachromosomal viral DNA was not de novo reverse transcribed in astrocytes but most likely the products of intravirion reverse transcription present in the virus inoculum. Integrated HIV-1 DNA was not detected in assays sensitive to detect 2 integrated copies of provirus. However, the majority of astrocyte cultures released infectious virus that could be transmitted to CD4+ cells. Our findings suggest a novel pathway of HIV-1 uptake and release in astrocytes that does not necessarily require virus replication, which may contribute to persistence and spread of HIV-1 in the brain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16445956     DOI: 10.1016/j.virol.2005.12.004

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  29 in total

Review 1.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

2.  Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues.

Authors:  Melissa J Churchill; Paul R Gorry; Daniel Cowley; Luxshimi Lal; Secondo Sonza; Damian F J Purcell; Katherine A Thompson; Dana Gabuzda; Justin C McArthur; Carlos A Pardo; Steven L Wesselingh
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

3.  Lymphocytic choriomeningitis virus (LCMV) infection of CNS glial cells results in TLR2-MyD88/Mal-dependent inflammatory responses.

Authors:  Shenghua Zhou; Annett Halle; Evelyn A Kurt-Jones; Anna M Cerny; Ermelinda Porpiglia; Michael Rogers; Douglas T Golenbock; Robert W Finberg
Journal:  J Neuroimmunol       Date:  2008-02       Impact factor: 3.478

4.  Enigma of HIV-1 latent infection in astrocytes: an in-vitro study using protein kinase C agonist as a latency reversing agent.

Authors:  Ashok Chauhan
Journal:  Microbes Infect       Date:  2015-06-02       Impact factor: 2.700

Review 5.  Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction.

Authors:  Shilpa Buch; Honghong Yao; Minglei Guo; Tomohisa Mori; Tsung-Ping Su; John Wang
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-16       Impact factor: 4.147

Review 6.  Interaction of astrocytes and T cells in physiological and pathological conditions.

Authors:  Luokun Xie; Shao-Hua Yang
Journal:  Brain Res       Date:  2015-03-23       Impact factor: 3.252

Review 7.  Cellular reservoirs of HIV-1 and their role in viral persistence.

Authors:  Aikaterini Alexaki; Yujie Liu; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2008-09       Impact factor: 1.581

Review 8.  Where does HIV hide? A focus on the central nervous system.

Authors:  Melissa Churchill; Avindra Nath
Journal:  Curr Opin HIV AIDS       Date:  2013-05       Impact factor: 4.283

9.  Chloroquine mediated molecular tuning of astrocytes for enhanced permissiveness to HIV infection.

Authors:  Theophilus S Vijaykumar; Avindra Nath; Ashok Chauhan
Journal:  Virology       Date:  2008-09-11       Impact factor: 3.616

10.  Human immunodeficiency virus-restricted replication in astrocytes and the ability of gamma interferon to modulate this restriction are regulated by a downstream effector of the Wnt signaling pathway.

Authors:  Deborah Carroll-Anzinger; Anvita Kumar; Vyacheslav Adarichev; Fatah Kashanchi; Lena Al-Harthi
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.